Bard Peripheral Vascular Inc SAFE-T PLUS LUMBARPUNCTURE TRAY ADULT Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
SAFE-T PLUS LUMBARPUNCTURE TRAY ADULT
Brand
Bard Peripheral Vascular Inc
Lot Codes / Batch Numbers
Catalog Number: 4306CSP Lot Numbers/UDI (GTIN
Products Sold
Catalog Number: 4306CSP Lot Numbers/UDI (GTIN, DI + PI): 0001410708 (01)10885403107795(17)220331(10)0001410708 0001411191 (01)10885403107795(17)220331(10)0001411191 0001412491 (01)10885403107795(17)220331(10)0001412491 0001413309 (01)10885403107795(17)220331(10)0001413309 0001416352 (01)10885403107795(17)220430(10)0001416352 0001417049 (01)10885403107795(17)220430(10)0001417049 0001420356 (01)10885403107795(17)220430(10)0001420356 0001421923 (01)10885403107795(17)220630(10)0001421923 0001422376 (01)10885403107795(17)220630(10)0001422376 0001425371 (01)10885403107795(17)220630(10)0001425371 0001426677 (01)10885403107795(17)220630(10)0001426677 0001429128 (01)10885403107795(17)220630(10)0001429128 0001432172 (01)10885403107795(17)220630(10)0001432172 0001433264 (01)10885403107795(17)220831(10)0001433264 0001433845 (01)10885403107795(17)220930(10)0001433845 0001437662 (01)10885403107795(17)221031(10)0001437662
Bard Peripheral Vascular Inc is recalling SAFE-T PLUS LUMBARPUNCTURE TRAY ADULT due to Due to lumbar puncture tray manometer failure mode of leaking and mating issues.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Due to lumbar puncture tray manometer failure mode of leaking and mating issues.
Recommended Action
Per FDA guidance
Between 01/28 and 02/01/2022, the firm sent an "URGENT MEDICAL DEVICE CORRECTION" Letter via email and FedEx 2-day mailings to customers informing them that between 07/02 to 12/15/2021 the firm received 59 customer complaints for lumbar puncture tray manometers with reported failure modes of leaking and mating issues. Customers are asked to take the following actions: 1. Check all inventory locations within their institution for the product listed in Table A and immediately destroy all affected product remaining in their possession. The product should have the sterile barrier broken and destroyed per their local facility s destruction process. 2. Share this notification with all users within their facilities to ensure they are also aware of this Urgent Medical Device Correction. 3. If Customers purchased this product from a distributor, contact their distributor for further instructions and credit resolution. 4. Complete and return the attached Customer Response Form to the Recalling Firm contact noted on the form confirming acknowledgement of the correction notification, whether or not they have any affected product, so that the Recalling Firm may acknowledge their receipt of this notification and process their credit. 5. Indicate on the response form the quantity of affected product identified at their facility and confirm that this inventory was destroyed. 6. Contact their Recalling Firm's representative to assist in this process or they may also contact the listed in the notification for further assistance. For further assistance contact: North American Regional Complaint Center - 1-844-8BD- LIFE (1-844-823-5433), Say Recall when prompted M-F 8am - 5pm CT
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026